Literature DB >> 26927583

Estimating covariate-adjusted measures of diagnostic accuracy based on pooled biomarker assessments.

Christopher S McMahan1, Alexander C McLain2, Colin M Gallagher1, Enrique F Schisterman3.   

Abstract

There is a need for epidemiological and medical researchers to identify new biomarkers (biological markers) that are useful in determining exposure levels and/or for the purposes of disease detection. Often this process is stunted by high testing costs associated with evaluating new biomarkers. Traditionally, biomarker assessments are individually tested within a target population. Pooling has been proposed to help alleviate the testing costs, where pools are formed by combining several individual specimens. Methods for using pooled biomarker assessments to estimate discriminatory ability have been developed. However, all these procedures have failed to acknowledge confounding factors. In this paper, we propose a regression methodology based on pooled biomarker measurements that allow the assessment of the discriminatory ability of a biomarker of interest. In particular, we develop covariate-adjusted estimators of the receiver-operating characteristic curve, the area under the curve, and Youden's index. We establish the asymptotic properties of these estimators and develop inferential techniques that allow one to assess whether a biomarker is a good discriminator between cases and controls, while controlling for confounders. The finite sample performance of the proposed methodology is illustrated through simulation. We apply our methods to analyze myocardial infarction (MI) data, with the goal of determining whether the pro-inflammatory cytokine interleukin-6 is a good predictor of MI after controlling for the subjects' cholesterol levels.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  AUC; Biological markers; Biomarker pooling; ROC curve; Youden's index

Mesh:

Substances:

Year:  2016        PMID: 26927583      PMCID: PMC6234508          DOI: 10.1002/bimj.201500195

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  28 in total

1.  Regression models for disease prevalence with diagnostic tests on pools of serum samples.

Authors:  S Vansteelandt; E Goetghebeur; T Verstraeten
Journal:  Biometrics       Date:  2000-12       Impact factor: 2.571

2.  Adjusting the generalized ROC curve for covariates.

Authors:  Enrique F Schisterman; David Faraggi; Benjamin Reiser
Journal:  Stat Med       Date:  2004-11-15       Impact factor: 2.373

3.  Pooling biospecimens and limits of detection: effects on ROC curve analysis.

Authors:  Sunni L Mumford; Enrique F Schisterman; Albert Vexler; Aiyi Liu
Journal:  Biostatistics       Date:  2006-03-10       Impact factor: 5.899

4.  Estimation of ROC curves based on stably distributed biomarkers subject to measurement error and pooling mixtures.

Authors:  Albert Vexler; Enrique F Schisterman; Aiyi Liu
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

5.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

6.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

Authors:  W Koenig; M Sund; M Fröhlich; H G Fischer; H Löwel; A Döring; W L Hutchinson; M B Pepys
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

7.  Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; Torbjorn Omland; Sarah Sloan; Petr Jarolim; Scott D Solomon; Marc A Pfeffer; Eugene Braunwald
Journal:  Circulation       Date:  2011-12-16       Impact factor: 29.690

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

10.  Bias, efficiency, and agreement for group-testing regression models.

Authors:  Christopher R Bilder; Joshua M Tebbs
Journal:  J Stat Comput Simul       Date:  2009-01-01       Impact factor: 1.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.